Innovation for Growth Summit

Science Museum, London
24 November 2025

Foreword

In order to achieve above-average economic growth, a company, or even a country, usually has an asset which differentiates it from its peers. The UK’s biggest, perhaps only, differentiating asset from other major economies is the quality of our research and innovation system, which by most metrics is, per capita, best in the world.

UK Research and Innovation (UKRI) invests around £10 billion of taxpayers’ money each year. Our responsibility is to ensure this investment delivers meaningful outcomes for the UK public by advancing knowledge, improving lives, and driving economic growth. We will do this not only by championing world-class, curiosity-driven research, but by delivering the research and innovation (R&I) needed to meet government priorities and by enabling companies to start, to scale, and ultimately to stay in the UK. 

In my view, the UK tries to do too much. We must be clear-eyed about where we can lead on the global stage and then back those areas concertedly. That means making choices, prioritising with intent, and stopping what no longer serves our strategic goals. The Government’s recent Industrial Strategy white paper sets out a clear direction for the sectors that matter most to our future economy. UKRI is responding with strategic realignment to these priorities.  

We are fortunate to have an exceptional R&I community. UKRI’s role is to amplify and accelerate its impact. That means working in true partnership with business, research organisations and investors, with longer-term commitment to our partners; being more inventive in how we construct joint programmes; and, perhaps most importantly, being deliberately more choiceful. This Innovation for Growth Summit is an important step in building those partnerships.

Professor Sir Ian Chapman
CEO, UKRI

Programme details
12:30-14:15

Time

Session

12:30

Registration and welcome tea/coffee
Innovation showcase

13:00

Welcome
Professor Sir Ian Chapman, CEO, UKRI 

Video Message
The Rt Hon Rachel Reeves MP
Chancellor of the Exchequer

Opening remarks
Rt Hon Liz Kendall MP 
Secretary of State for Science, Innovation and Technology 

13:30

The innovation dividend: Turning discovery into national prosperity
What will it take to make R&I the UK’s defining competitive edge? Leaders from government, tech and investment share their insights on scaling discovery, accelerating innovation and driving the next wave of economic transformation.

Speakers
Lord Vallance, Minister of State for Science, Innovation, Research and Nuclear
Edward Bussey, CEO, Oxford Science Enterprises
Dr Alicia Greated, Executive director, Campaign for Science and Engineering (CaSE)

Chair
Nigel Toon, Co-founder, Chair and CEO at Graphcore; UKRI Board member

Breakout sessions
14:15-15:20

Session 1 – Illuminate 5

Session 2 – Illuminate 4

Session 3 – Smiths Centre

Global trends, UK advantage: Harnessing R&I for strategic growth

Mission driven innovation: Powering the future

Science to scale: Powering innovation from discovery to impact

Around the world, countries are doubling down on R&I to fuel economic resilience, technological leadership, and national security. From AI and clean tech to life sciences and advanced manufacturing, global competition for talent, investment and ideas is intensifying.

The UK has set out its ambition to be a science and innovation superpower, backed by reforms to R&I funding and industrial strategy. This session will anchor that direction and ask our panellists: how can we go further to leverage the UK’s unique strengths in AI, clean tech and life sciences to win in a globally competitive landscape?

With the UK’s new 10-year industrial strategy, R&I must be more than a system of discovery – it must become a strategic driver of national outcomes. The strategy highlights long-term investment, innovation and cross-sector collaboration as essential to delivering growth across key industries such as clean energy, AI, life sciences, and advanced manufacturing.

This session will highlight these priorities and recent reforms to how funding is structured. It will explore what more is needed – through collaboration, policy and investment – to accelerate delivery and ensure real-world impact.

Britain is a global leader in scientific discovery and early-stage innovation – but too often, breakthrough ideas struggle to grow into global enterprises. The UK’s scale-up gap risks holding back economic potential, investment returns and national competitiveness.

Recent measures through Innovate UK and the British Business Bank are strengthening the scale-up environment for UK innovators. Building on these reforms, this session will explore what further steps could help high-growth companies move from discovery to global impact. It will ask where we can double down to make the UK the best place in the world to grow innovation-led businesses.

Speakers
Carl Ennis, CEO, Siemens UK

Dr Anna Valero, Distinguished Policy Fellow at the Centre for Economic Performance, LSE

Professor Adam Tickell, Vice-Chancellor and Principal, University of Birmingham

Naomi Weir, Director of Technology and Innovation, CBI

Liz Rosenthal, CEO, Power to the Pixel

Speakers
Sir John Lazar CBE, President, Royal Academy of Engineering

Dr Laura Gilbert CBE, Senior Director of AI, Tony Blair Institute

Emma Pinchbeck, CEO, Climate Change Committee

Rt Hon Greg Clark, Executive Chair, University of Warwick Innovation District

Speakers
Dr Harry Destecroix MBE, Founder, Science Creates ecosystem; Founder & Managing Partner, SCVC

Dr Lia Li, CEO, Zero Point Motion

Simon King, Partner, Lakestar; EPSRC Council Member

Chair
Stian Westlake, Executive Chair, Economic and Social Research Council (ESRC)

Chair
Nola Hewitt-Dundas, Professor of Innovation Management and Policy and Pro Vice-Chancellor (Arts, Humanities and Social Sciences), Queen’s University Belfast; Member, UKRI Board

Chair
Tom Adeyoola, Executive Chair, Innovate UK

Programme details
15:20-17:45

Time

Session

15:20

Refreshments break

15:45

Real world impact: How tech is changing the world
From breakthroughs in AI and clean energy to life-saving health innovations, UK projects are transforming lives and markets. This session shines a spotlight on the stories of innovation making a tangible difference – proof that the UK’s R&I strength is not only about discovery but also about improving lives and livelihoods.

Speakers 
Dr Alison Buick, Head of Global Business Development, Cumulus Neuroscience  
Dr Edwin Stone, CEO, Cellular Origins   
Alexandra French, CEO, Xampla
Dr Steve Wells, Chief Technology Officer, Adaptix

Chair 
Professor Charlotte Deane, Executive Chair, Engineering and Physical Sciences Research Council (EPSRC) 

16:30

Closing plenary panel
Vision 2035: R&I as the foundation of Britain’s future
This closing plenary brings together visionary leaders from across government, science and innovation to explore the long-term ambition for the UK’s R&I system. This discussion will link strategic direction with economic growth. It will ask: what choices made today will ensure the UK builds an R&I ecosystem capable of sustained growth, global influence and resilience by 2035?

Speakers
Sir Paul Nurse, President Elect, Royal Society; Honorary Life President & Principal Group Leader, Francis Crick Institute  
Professor Dame Nancy Rothwell DBE, Deputy Chair, Industrial Strategy Advisory Council
Professor Dame Angela Mclean DBE, Government Chief Scientific Adviser
Rita Dhut, Chair, JP Morgan European Growth and Income PLC; Member, UKRI Board

Chair
Professor Sir Ian Chapman, CEO, UKRI

17:30

Closing remarks
Professor Sir Ian Chapman, CEO, UKRI

17:45

Stakeholder reception
Sponsored by NCUB

Speakers

Tom Adeyoola

Executive Chair, Innovate UK
Tom brings a wealth of experience spanning technology, investment, entrepreneurship and digital transformation to his role as Executive Chair of Innovate UK. He previously grew his fashion technology startup Metail to exit raising £25 million, took women’s personal wellness scale-up Elvie from inception to Series B, and took net zero strategy consultancy Verco through to acquisition. He also serves on the steering board of The Startup Coalition, advocating for high-growth tech businesses across the UK.

Dr Alison Buick

Head of Global Business Development, Cumulus Neuroscience
With a background in psychology and neuroscience, Alison is focused on integrating technology into healthcare. Prior to joining Cumulus Neuroscience in 2017, her academic research in the UK, Ireland and Canada explored neurophysiological interventions and medical devices for remote use. Currently, her focus is on building strategic partnerships with biopharma to drive adoption of innovative digital technologies for acceleration and enrichment of clinical trials. The ultimate goal is to deliver faster, more effective healthcare outcomes for patients.

Edward Bussey

CEO, Oxford Science Enterprises
Edward is responsible for leading OSE’s mission to build transformational companies from Oxford’s world-class research. A serial entrepreneur, he has launched, scaled and successfully exited three disruptive technology businesses. Recognised as a technology thought leader in the UK, he has been awarded ‘UK Entrepreneur of the Year’, ‘Disruptor of the Year’, and is a member of the Oxford-Cambridge SuperCluster Board. Edward began his career serving in the UK military and national security agencies. 

Professor Sir Ian Chapman

CEO, UK Research and Innovation
Ian rejoined the UKRI Board as CEO in August 2025, where he is leading a mission that puts economic growth at the heart of public investment in research and innovation. Before joining UKRI, Ian was Chief Executive of the UK Atomic Energy Authority and held several international roles in fusion, including chairing the International Atomic Energy Agency International Fusion Research Committee. His research has been recognised with multiple international awards, and in 2023, he was knighted in the King’s New Year Honours, made an Honorary Fellow of the Nuclear Institute and elected a Fellow of the Royal Society.

Rt Hon Greg Clark

Executive Chair, University of Warwick Innovation District
Former Cabinet Minister Greg Clark is Executive Chair of Warwick Innovation District and Chair of the Warwick Manufacturing Group. Greg served for 19 years as a Member of Parliament, before stepping down in 2024. He served in the UK Cabinet as Secretary of State for Business, Energy and Industrial Strategy, Secretary of State for Communities and Local Government, Minister for Science and Universities. He is a member of the Industrial Strategy Advisory Council (ISAC), which contributes to the development and delivery of the Government’s industrial strategy.

Professor Charlotte Deane

Executive Chair, Engineering and Physical Sciences Research Council (EPSRC)
Charlotte is Executive Chair at EPSRC, Professor of Structural Bioinformatics in the Department of Statistics at the University of Oxford and co-director of the Systems Approaches to Biomedical Research Centre for Doctoral Training. From 2022 to 2023 she was Chief AI Officer at biotech company Exscientia. Charlotte is on several advisory boards and has consulted extensively with industry. She has set up a consulting arm within her own research group as a way of promoting industrial interaction.

Dr Harry Destecroix

CEO, Science Creates
Harry is a scientist, entrepreneur and investor. He founded Science Creates and SCVC, a venture firm backing category-defining Deep Tech startups. During his chemistry PhD, he founded Ziylo, acquired by Novo Nordisk in 2018 in a deal worth up to $800 million, and later co-founded Carbometrics to advance the technology. Before that, in 2017, he built Bristol’s first Deep Tech incubator, which was the foundation of the Science Creates ecosystem. Harry was awarded an MBE in the King’s 2025 New Year Honours List for his services to science. 

Rita Dhut

Chair, JP Morgan European Growth and Income PLC
Rita is experienced investor and supporter of innovative businesses, with more than 30 years of experience spanning private and public markets, covering early to institutional stages of investment. She currently serves as Chair of JP Morgan European Growth and Income Plc and as a Non-Executive Director on the boards of Integrafin Plc and Ashoka India Equity Plc. With a diverse background in finance, she has held key roles on various committees, including audit, risk, renumeration and cybersecurity. Rita is a member of the UKRI Board.

Carl Ennis

CEO, Siemens UK
Carl is Chief Executive of Siemens plc and Siemens Smart Infrastructure. He has worked in the power and infrastructure industries for more than 35 years. Having started his career as an apprentice, he is a keen advocate of the skills and diversity agendas. Carl is a Chartered Engineer and a fellow of the Institution of Engineering & Technology. He is also a member of the Government’s Investment Council, represents Siemens on the Department for Energy, Security and Net Zero’s (DESNZ) Energy Efficiency Task Force and Net Zero Council.

Alexandra French

CEO, Xampla
Alexandra is an experienced chemist with a degree in Natural Sciences from the University of Cambridge. She has extensive global commercial and business leadership experience from 25 years at Johnson Matthey, a multinational specialty chemicals and sustainable technologies company. She was CEO of AIM listed business Titon Holdings prior to joining Xampla as CEO in October 2023. She is an accredited coach and is passionate about helping people grow and develop. 

Dr Laura Gilbert

Senior Director of AI, Tony Blair Institute
Laura runs the Tony Blair Institute AI Innovation Lab. From Sept 2020 to Jan 2025 she worked in 10 Downing Street as the founding director of both 10DS, the data science and analytics team, and the Incubator for Artificial Intelligence (i.AI). Laura holds a doctorate in Particle Physics from the University of Oxford, undergraduate degrees from the University of Cambridge and is a Visiting Professor at LSE. In 2023 she was awarded a CBE for services to technology and analysis.

Dr Alicia Greated

Executive Director of the Campaign for Science and Engineering (CaSE)
CaSE is leading policy influence in UK R&D and Alicia joined them in April 2024, following senior roles including CEO of the Knowledge Transfer Network and Global Director of Research and Enterprise at Heriot-Watt University. Alicia previously held leadership positions at UK Research Councils, founding RCUK India and China. She is a Fellow of the Royal Society of Edinburgh and the Institution of Engineering and Technology, and serves on advisory boards including the Royal Society’s Science, Industry and Translation Committee and the Strategic Board of Interface.

Professor Nola Hewitt-Dundas

Pro-Vice-Chancellor and Professor of Innovation Management & Policy, Queen’s University Belfast
Nola is an internationally recognized academic whose research has focused on innovation systems, university-business relationships and science policy. With over 100 peer-reviewed publications she has served as a UK REF sub-panel member and recently appointed to the Hong Kong research assessment exercise. With various international advisory and consultancy engagements, Nola was appointed in 2022 as a member of the UKRI Board.

Rt Hon Liz Kendall MP

Secretary of State for Science, Innovation and Technology
Liz was elected as the Labour MP for Leicester West in 2010 and served as Secretary of State for Work and Pensions before her appointment as Secretary of State for Science, Innovation and Technology in September 2025. Passionate about creating a fairer society and improving public services, she previously worked for think tanks the Institute for Public Policy Research and the King’s Fund, as well as the Ambulance Service Network and Maternity Alliance.

Simon King

Partner, Lakestar; EPSRC Council Member
Simon King is a Partner at Lakestar, where he focuses on deeptech investments. He works closely with founders operating at the frontier of technology, helping turn scientific breakthroughs into commercial reality. Simon also serves as a member of the Engineering and Physical Sciences Research Council (EPSRC) Council. Previously, Simon was a Partner at Octopus Ventures, leading a team that invested in technology-rich businesses. With 14 years of experience in venture capital, he is deeply passionate about emerging technologies and their potential to positively transform lives.Before moving into investing, Simon built a strong academic foundation in physics, chemistry, and materials science, culminating in a PhD in plastic electronics from Imperial College London.

Sir John Lazar CBE FREng

President, Royal Academy of Engineering
John is a software engineer and entrepreneur with experience of building and managing successful global businesses. Sir John was elected as a Fellow of the Royal Academy of Engineering in 2011 and chaired the Academy’s Enterprise Committee, which supports startups and scaleups across the UK and globally through the Enterprise Hub. He is Chair of the Raspberry Pi Foundation, which aims to help young people realise their full potential through the power of digital technologies.

Dr Lia Li 

CEO, Zero Point Motion 
Lia is founder of Zero Point Motion, an innovative tech company that develops chip-scale inertial sensors that measure motion and rotation – these sensors are found in cars, phones, robots and motion capture wearables. Lia has a PhD in cavity optomechanics from University College London, as well as a wealth of experience from her work in laser development at Imperial College and sensor innovation at BAE Systems. She holds four granted patents and has three pending.

Professor Dame Angela Mclean

Government Chief Scientific Adviser
Angela took up the role of Government Chief Scientific Adviser in April 2023. She is also Head of the Government Science and Engineering Profession. Prior to this she was the Chief Scientific Adviser for the Ministry of Defence. Angela was a Professor of Mathematical Biology at Oxford University and a Fellow of All Souls College. Her research interests lie in the use of mathematical models to aid our understanding of the evolution and spread of infectious agents.

Sir Paul Nurse

Honorary Life President, Francis Crick Institute; President Elect, Royal Society
Paul is the honorary life president and principal leader of the Francis Crick Institute and has been elected as the next President of the Royal Society. He is a geneticist and cell biologist whose discoveries have helped to explain how the cell controls its cycle of growth and division. His contributions to cell biology and cancer research were recognised with a knighthood in 1999. In addition, Paul’s endeavours relating to the discovery of cell cycle regulatory molecules saw him jointly awarded the Nobel Prize for Physiology or Medicine in 2001.

Emma Pinchbeck

CEO, Climate Change Committee
Emma is the Chief Executive of the Climate Change Committee, the UK’s national climate advisor. She is an expert in whole-economy decarbonisation and the energy transition and is a Fellow of the Energy Institute. From 2020-2024, Emma was the Chief Executive of Energy UK, and from 2016-2020, she served as deputy CEO of the trade body Renewable UK. Earlier in her career, Emma worked in finance and in commercial consulting for start-ups in the energy sector. 

Liz Rosenthal

CEO, Power to the Pixel
Liz is the founder of Power to the Pixel, an organisation helping international film and media businesses adapt to stay relevant to digital and changing audiences. She is also the Curator of Venice Immersive, the Venice Biennale’s official XR programme at the Venice International Film Festival, and Executive Producer for CreativeXR, an immersive content accelerator programme. Liz began her media career in the film business and is an expert in devising innovation-centred development labs, programmes and exhibitions around immersive and interactive entertainment and art.

Professor Dame Nancy Rothwell

Deputy Chair, Industrial Strategy Advisory Council
Nancy is a British physiologist who served as president and vice-chancellor of the University of Manchester between 2010 and 2024. She was non-executive director of AstraZeneca between 2006 and 2015, and was previously co-chair of the Council for Science and Technology. Her research in the field of neuroscience has contributed towards major advances in the understanding and treatment of brain damage in stroke and head injury. She was awarded a damehood for her services to science in 2005.

Dr Edwin Stone

CEO, Cellular Origins
Edwin has spent over two decades bringing breakthrough life science technologies from concept to market, the last ten dedicated to solving the challenge of how to manufacture cell therapies at scale. He has been involved in the development of over 10 novel cell therapy automation platforms and now leads Cellular Origins’ mission to enable broad patient access to advanced cell therapies. Edwin holds a Master’s degree in Engineering and a PhD in Robotic Vehicles from the University of Cambridge.

Professor Adam Tickell

Vice-Chancellor and Principal, University of Birmingham
Adam trained as an economic geographer at the University of Manchester, where his research explored the political economy and regulation of finance, English regionalism, and the economic ‘common sense’. He has also held leadership roles at the University of Sussex, University of Bristol, Royal Holloway and University of London. In November 2024, Adam was appointed as a non-executive director at the Department for Science, Innovation and Technology (DSIT) to guide the use of science and technology to enhance public services, promote digital inclusion and drive economic growth.

Nigel Toon

CEO, Graphcore
Nigel has a background as a technology business leader, entrepreneur and engineer.  Prior to co-founding Graphcore, he was CEO at two successful venture capital-backed proces­sor companies and co-founder and board director at Icera, a 3G cellular modem chip company, which was sold to NVIDIA in 2011 for $435M. He was previously a senior executive at a major Silicon Valley, publicly listed semiconductor company, and is the author of three granted patents. Nigel is a member of the UKRI Board.

Lord Vallance

Minister of State for Science, Innovation, Research and Nuclear
As Minister for Science, Innovation, Research and Nuclear, Patrick is responsible for advancing the UK’s science and innovation ecosystem. He previously served as the Government Chief Scientific Adviser from April 2018 to April 2023 and as National Technology Adviser. Prior to this, Patrick was President, R&D at GlaxoSmithKline. He has also worked as a clinic academic, Professor of Medicine and led the Division of Medicine at University College London. He has many years of experience in basic science and clinical research and was a consultant physician in the NHS. 

Dr Anna Valero

Distinguished Policy Fellow at the Centre for Economic Performance, LSE
Anna is a Distinguished Policy Fellow and Director of the Growth Programme at the LSE’s Centre for Economic Performance, Deputy Director of the Programme on Innovation and Diffusion, and an Associate of the Grantham Research Institute, LSE. Her research is focused on the drivers of productivity and innovation in firms and regions. Anna was a member of the Steering Group of the Economy 2030 Inquiry. She is currently serving as Industrial Strategy adviser to the Chancellor of the Exchequer, having previously served as a member of the Council of Economic Advisers over 2024-25.

Naomi Weir

Director of Technology and Innovation, Confederation of British Industry
Naomi leads the CBI’s work to make the UK a great place for businesses to innovate, whether that is nurturing a culture of entrepreneurship, adopting tried and tested technologies or making breakthrough developments at the leading edge. She began her career in financial services before moving into policy, working on policy areas including research and development, entrepreneurship, skills, immigration and diversity in STEM. 

Dr Steve Wells

Chief technology officer, Adaptix
Steve Wells spent 12 years developing medical devices for Siemens Molecular Imaging before joining Adaptix. He has a PhD in Neuroscience, MSc in Medical Physics and a Natural Sciences degree from Cambridge. Prior to Siemens he worked as a software engineer on various commercial science projects.

Stian Westlake

Executive Chair, Economic and Social Research Council (ESRC)
Stian’s research interests include the economics and politics of innovation, research and technology. He is a regular commentator on science and innovation policy, and co-author of ‘Restarting the Future: How to Fix the Intangible Economy’ and ‘Capitalism Without Capital: The Rise of the Intangible Economy’. Before taking the role of Executive Chair at ESRC, he served as Chief Executive of the Royal Statistical Society, as Executive Director of Policy and Research at Nesta, as adviser to three UK science ministers and as a management consultant with McKinsey & Company.

Projects

Developing robotic hands

Who? Shadow Robot

What? Shadow Robot specialises in developing robotic hands – next-generation robot systems with advanced dexterity – to solve real-world problems. In collaboration with Google Deepmind, the company has created DEX-EE, a new robotic hand to meet the needs of researchers working on real-world machine-learning projects. DEX-EE is super-dexterous and sensitive, yet robust enough to survive collisions and crashes that would break most robots.

Growth highlights The company has grown from a team of six robot enthusiasts meeting in an attic in the 1980s to a thriving company of 40 people creating state-of-the-art robot hardware used all over the world in robotics research. Support from Innovate UK has helped Shadow Robot explore applications of robot technology in new areas and transfer research innovation into its systems. The company has worked with major organisations across the globe, including NASA, GSK and Siemens.

Early warning of airborne pathogens

Who? Agnos Biosciences

What? Agnos Biosciences is a spin-out founded this year to commercialise AirSeq, DNA sequencing-based technology able to detect minute traces of pathogens in the air. It was originally conceived as a surveillance tool for pathogens that threaten agricultural crops, however, AirSeq has a broad range of applications, including biosecurity, food manufacturing and public health. It could be installed in high-footfall areas such as hospitals, mass-transportation hubs and even entertainment venues.

Growth highlights More than a decade of Biotechnology and Biological Sciences Research Council funding facilitated the development of the core technology at the Earlham Institute. Agnos Biosciences is now offering AirSeq as a service with the ability to process air samples within a few hours, delivering results through its web-based bioinformatics platform MARTi. It is early stages for the company but it has already secured customers and orders.

Vertical airfields for city centres

Who? Urban-Air Port

What? Urban-Air Port designs, manufactures and operates ground, air and digital infrastructure for new forms of sustainable urban air transport, such as air taxis and autonomous delivery drones. Its Air One Next-Gen replaces a conventional airfield required for take-off and landing with a ‘vertical’ airfield that acts like an aircraft carrier onshore. The company has also developed cutting-edge defence technology with its Pandora launch system for unmanned aerial vehicles.

Growth highlights With support from the Future Flight Challenge Programme, in 2022 Urban-Air Port completed a world-first demonstration of its vertiport technology in Coventry city centre. It plans to deliver over 200 vertiports across the world over the next five years. The company has supported more than 250 jobs across multiple sectors and its portfolio includes Aerospace giant Airbus and leading automotive manufacturers Hyundai Motor Group and Honda.

Natural packaging from seaweed and plants

Who? Notpla

What? Sustainable packing innovator Notpla was the first company in the world to produce natural food packaging made from seaweed. Its range of disposable food-to-go packaging has already displaced over 30 million items of single-use plastic. The company’s growing range provides sustainable solutions for everyday applications, including food containers, pipettes for oils, and dissolving pods and films. Notpla was awarded Prince William’s Earthshot Prize for its impact in tackling waste at scale across the world.

Growth highlights The London-based company was the first to manufacture natural food packaging at industrial scale in the UK. It now employs 57 people and, last year, saw revenue rise to £2.7 million. Notpla has received £3 million of funding from Innovate UK over the past decade, alongside private investment, helping drive development and scale-up across its product portfolio. It has secured multi-million-pound contracts from major food caterers.

Plastic-free, plant-powered materials

Who? Xampla

What? Xampla is a materials innovation company that harnesses the power of plants to create natural materials designed to eliminate the world’s most polluting plastics. Its patented technology is rooted in over 15 years of research at the University of Cambridge.

Xampla’s range of Morro™ materials offer high-performance, plastic-free alternatives for industries and applications such as barrier coatings, flexible films, and edible packaging. These plant-based materials are produced without chemical modification, making them fully biodegradable and suitable for home composting.

Growth highlights Supported by Innovate UK funding, Xampla was able to develop its materials and expand its intellectual property portfolio. This paved the way for its first product launch earlier this year with Just Eat Takeaway – a corrugated takeaway box featuring Xampla’s plastic-free Morro™ Coating. It also gave investors confidence, resulting in a successful $14 million Series A funding round. Headquartered in Cambridge, Xampla now employs 40 people.

Ultra-fast charging technologies

Who? Nyobolt

What? Nyobolt is a pioneer in high-power, fast-charging energy solutions. It has developed a concept car based on its innovative battery technology that can charge from 10% to 80% in less than five minutes – eliminating the problem of lengthy waits for EV drivers. The company has successfully scaled its technology from its origins in materials discovery at Cambridge University to now providing customers in sectors such as AI data centres, warehouse robotics, automotive, and electrified heavy-duty applications with advanced high-power energy systems.

Growth highlights With UKRI funding, Nyobolt has accelerated the scale-up of its materials manufacturing in the UK and fuelled the company’s growth by helping to secure investment and commercial interest. The business now employs 120 people worldwide, with its headquarters in Cambridge and a new manufacturing plant in Haverhill, Suffolk. It has recently secured a deal to roll out its battery technology with a major US robotics firm.

Transforming radiology

Who? Adaptix

What? Adaptix is disrupting the imaging market with revolutionary 3D X-ray technology. Currently, the most commonly used medical imaging device is a 2D X-ray but this provides a limited view of the body, while existing 3D scanners are large and immobile. Adaptix is developing new, portable imaging technology that offers 3D imaging at a similar cost and radiation dose to traditional 2D X-rays.

Growth highlights Founded in 2014, the company now employs 70 people and secured over £20 million in private investment before being acquired by Avingtrans plc in 2023. Support from Innovate UK helped product development and, earlier this year, Adaptix and the University of Exeter conducted the first human trials using Adaptix’s Ortho350. This mobile 3D X-ray system can generate 3D images of hands, elbows, shoulders, knees and feet in less than 20 seconds, greatly enhancing the information available for diagnosis

Flexible chips that can go where others can’t

Who? Pragmatic Semiconductor

What? Pragmatic Semiconductor is a pioneer in low-cost, flexible semiconductor technology. The ultra-thin, physically flexible circuits in its NFC Connect can be embedded easily into products and packaging, enabling customers to connect with one tap of a smartphone. Unlike traditional chips, the company uses thin-film transistor technology, which can be produced with less energy and water, and fewer harmful chemicals.

Growth highlights Founded in 2010, Pragmatic Semiconductor now employs more than 350 people across its HQ in Cambridge and manufacturing facility in Durham, with a further 500 jobs anticipated over the next five years. The company was the recipient of Europe’s largest ever venture funding round for a semiconductor company, achieving £182 million. It has received support from Innovate UK across a number of projects exploring different applications, such as in food waste and the circular economy.

Wider access to life-saving treatments

Who? Cellular Origins

What? Cell therapies have the potential to cure diseases previously thought unsurvivable. However, current manufacturing processes are creating bottlenecks and holding back progress – threatening the industry’s ability to deliver these life-saving therapies. Cellular Origins is revolutionising cell therapy manufacturing. Using mobile robotics and AI, it is enabling patient access to cell therapy at scale.

Growth highlights Funding from Innovate UK helped support testing and roll out of Cellular Origins’ Constellation technology. The first installation of an autonomous factory has been agreed for 2026, reaching commercial scale in 2029. By 2030, Cellular Origins expects to have installed systems capable of producing up to 100,000 therapies per year, with more installations scheduled every few months.The Cambridgeshire-based company now employs 80 people and has secured tens of millions of pounds of private investment and funding tied to delivery of its systems.

Transforming dementia research

Who? Cumulus Neuroscience

What? Cumulus Neuroscience has developed the NeuLogiq® Platform, which enables people to participate in clinical trials for conditions such as Alzheimer’s disease from the comfort of their home. The digital biomarkers from these studies have the potential to transform dementia research – accelerating the discovery of new treatments, and improving drug target identification and dosing.

Growth highlights Founded in 2015, the Belfast-based company has grown to 32 staff and secured venture capital investments and grants of more than £15 million. UKRI support enabled Cumulus Neuroscience to develop its NeuLogiq® Platform and portable EEG headset. Having spent the first seven years in technology development and validation, the company now has a strong commercial focus, licensing its technology to BioTech and Pharma to enrich and accelerate clinical trials in neurodegeneration and psychiatry.

Sponsor

The National Centre for Universities and Business (NCUB)

The National Centre for Universities and Business (NCUB) helps UK businesses, universities and policymakers work together towards a prosperous future through greater collaboration across education, research and innovation.

As a strategic network and independent charity made up of experts and sector specialists, we do this in three ways:

We inform
By providing authoritative insight on R&D, innovation and skills, and by sharing evidence of what works in building stronger partnerships.

We influence
By convening leaders in universities, business and government to debate strategic challenges, guide policymaking and generate new solutions.

We inspire
By championing collaboration in practice, showcasing its impact and opening new opportunities for businesses to engage with the UK research base.

Learn more about NCUB’s work at www.ncub.co.uk.